Clinical Trial Update: Developing a New LIFU Neuromodulation Method to Suppress Tremor [Phase 2]

View source ↗

Summary

A Phase 2 study is developing a low-intensity focused ultrasound neuromodulation method to suppress tremor in essential tremor, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Tremor

Snippet

Sponsor: University of Calgary | Conditions: Essential Tremor | Phase 2 | Status: NOT_YET_RECRUITING